Custom service
Magnetic Bead-Coupled Proteins and Nucleic Acids
Capture reagents with measured ligand density and honest capacity.
A magnetic bead reagent is defined by two numbers that are usually missing from the datasheet: how much ligand is actually on the bead, and how much target it captures. Coupling protocols that report only 'coupled according to protocol' hide both. Loading is measured here by protein or oligonucleotide assay, and capture capacity is measured with the target itself, because a fully loaded bead surface can still be a poor capture reagent if the ligand is oriented into the bead.
Coupling chemistry is matched to the ligand and the application. Passive adsorption works for some antibodies and polymer beads but leaches over time. Covalent coupling through NHS, epoxy or aldehyde groups fixes the ligand permanently. Affinity capture — biotin on streptavidin beads — gives the highest density and the most controlled orientation, with the ligand's biotin placed by design rather than by NHS randomness. For nucleic acids, 5' modifications couple through the same chemistries with defined spacing.
Blocking is part of the product, not an afterthought. Free binding sites are blocked with a matrix chosen for the downstream assay — BSA, casein, PEG or nucleic-acid blockers — and non-specific binding is measured against the negative control matrix the assay will use. The delivered reagent is titrated in the intended protocol, so the recommended bead quantity comes from measurement.
Coupled magnetic beads serve immunoprecipitation, pull-down and interaction screening, nucleic acid capture, cell sorting and immunoassay capture formats — anywhere the target must be separated with a magnet.
The service does not improve a weak ligand; capacity is bounded by the ligand's affinity, and a capture reagent built on a low-affinity antibody will measure poorly regardless of loading.
Each lot is delivered with measured ligand loading, capture capacity against the target, non-specific binding on the negative control matrix, leaching where relevant, and a recommended protocol with bead quantity and incubation conditions. Storage stability of the slurry is documented.
Service Highlights
- Loading measured. Ligand per milligram of beads quantified by protein or nucleic acid assay, reported per lot.
- Capacity measured. Capture capacity tested with the actual target, not inferred from loading.
- Orientation options. Biotin-streptavidin with site-specific biotin for oriented, high-density capture; covalent chemistry for permanence.
- Nucleic acid coupling. 5'-modified oligos coupled with defined density and spacing for hybridisation and pull-down.
- Blocking matched to assay. Blocker chosen for the downstream matrix, with non-specific binding measured against the real negative controls.
- Protocol-titrated. The reagent titrated in the intended protocol, so the recommended bead amount is empirical.
How the work runs
Bead and chemistry selection
Bead type, size and surface chemistry chosen against the ligand and the capture application.
Coupling optimisation
Ligand-to-bead ratio and reaction conditions titrated; loading verified by assay.
Preparative coupling
Coupling at the required scale under the optimised condition.
Blocking
Free sites blocked with the matrix matched to the downstream assay.
Capacity testing
Capture capacity measured with the target under assay-like conditions; non-specific binding measured against negative controls.
Delivery
Slurry supplied with loading, capacity, non-specific binding data and a recommended protocol.
Specifications & timeline
- Beads
- 0.5–5 µm magnetic beads; silica, polymer, streptavidin, carboxyl, epoxy and aldehyde surfaces
- Ligands
- Proteins, antibodies, enzymes, oligonucleotides, peptides
- Loading
- Measured per lot, typically 1–30 µg ligand per mg beads
- Applications
- IP/Co-IP, pull-down, cell sorting, nucleic acid capture, immunoassay
- Timeline
- 1–2 weeks per conjugate
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.